Solaris Endovascular, Inc. is a growth stage US-based medical device company developing advanced endovascular solutions for patients suffering from dialysis access challenges and Peripheral Artery Disease. With a proven stent platform and innovative drug-eluting technology, led by seasoned executives with extensive experience in cardiovascular MedTech, Solaris Endovascular is uniquely positioned and committed to improving long-term patient outcomes and transforming vascular health.
Company Details
- Employees
- 3
- Founded
- 2024
- Address
- 201 St. Charles Ave,
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- HQ
- New Orleans, LA
Solaris Endovascular Questions
Solaris Endovascular's website is http://www.solarisendovascular.com
Solaris Endovascular's LinkedIn profile is https://www.linkedin.com/company/solaris-endovascular
Solaris Endovascular has
3 employees.
View email and phone details for 3
employees at Solaris Endovascular.
Solaris Endovascular's industry is
Medical Equipment Manufacturing
Solaris Endovascular's top competitors are
Oncosil Medical,
Transradial Technologies Inc,
Aethlon Medical, Inc.,
Subsense Inc.,
E2 - Endovascular Engineering,
Scitech Medical,
Ligence,
Navi Medical Technologies,
Mybiometry,
Simbiosys.
Solaris Endovascular's categories are Medical Equipment Manufacturing
Solaris Endovascular's founding year is 2024
